Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 211754

In scope icon L 3 B
QID 211754 (Type "211754" in App Search)
Your 68-year-old neighbor, a retired military veteran, was diagnosed with non-valvular atrial fibrillation two years ago. His other chronic medical conditions include hypertension and diabetes mellitus. He has never had any surgery in the past. His heart rate has been appropriately controlled with calcium channel blockers. As a caring hand surgeon, you are concerned that he has the possibility of developing upper extremity thromboembolism secondary to his atrial fibrillation. What is the most likely treatment to reduce the likelihood of thromboembolism in the hand because of his specific cardiac condition?

Cholesterol medication

1%

21/1754

Antiplatelets

31%

546/1754

Antibiotics

0%

6/1754

Beta-blocker

5%

85/1754

Anticoagulants

62%

1085/1754

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

Atrial fibrillation (AF) is the most common cause of upper extremity thromboembolism and can be treated with anticoagulants by a cardiologist.

Acute non-traumatic hand ischemia has many potential causes and often requires a multidisciplinary approach to diagnose and treat. Up to 93% of acute upper extremity ischemia is from cardiac embolism. The most common cause of cardiac embolism is AF. Loss of atrial contractility and expulsion leads to stasis and thrombus development.

Zimmerman reviewed occlusive vascular disorders of the upper extremity. He discusses that arterial occlusive disease of the hand is usually secondary to posttraumatic occlusion of the ulnar artery. An embolic source is more likely in the setting of AF or following myocardial infarction, and venous occlusion is more likely when there is a hypercoagulable state.

Brinkley and Hepper review structural cardiac abnormalities that manifest as acute dysvascular conditions of the hand. They report that cardiomyopathy, valvular disease, atrial septal defects, and aortic arch abnormalities may all be associated with thromboembolism. However, the authors note that AF constitutes 80% of upper extremity thromboembolism.

Based on the 2014 AHA/ACC/HRS guideline for the management of patients with AF, those with any one high-risk factor or more than one moderate-risk factor should be treated with anticoagulation for non-valvular AF in addition to medication for heart rate control. The authors report that high-risk factors include prior stroke or transient ischemic attack, systemic thromboembolism, or age 75 years or older, while moderate-risk factors include age 65-74 years, female sex, hypertension, diabetes mellitus, heart failure, or arterial disease.

Incorrect Answers:
Answer 1: Ischemic cardiomyopathy, which may precipitate thromboembolism, may be treated with cholesterol medication.
Answer 2: Antiplatelet medication may be indicated for prophylaxis in patients with mechanical valves, which the patient does not have.
Answer 3: Antibiotics may be indicated in the setting of endocarditis, which can also precipitate septic thromboembolism.
Answer 4: A beta-blocker may control rate, but not rythm, so one is still at risk for thromboembolism.

REFERENCES (3)
Authors
Rating
Please Rate Question Quality

1.6

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(21)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options